ScholarWorks@Korea University: Ji, Jong Dae

Detailed Information

Ji, Jong Dae (지종대)

College of Medicine (Department of Medical Science)

Research Area

Tel 안5489
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Metaanalysis:25||Polymorphism:23||Rheumatoid arthritis:20||metaanalysis:9||polymorphism:7||Microarray:6||Macrophages:5||Systemic lupus erythematosus:5||TREM1:4||Osteoclast:4||Pathwaybased analysis:3||Inflammation:3||Osteoarthritis:3||microRNA:3||systemic lupus erythematosus:3||Ankylosing spondylitis:2||Vasculitis:2||Bioinformatics:2||Autoimmune diseases:2||Genomewide association study:2||Autoimmunity:2||IL6:2||Behcet&apos:2||INFLAMMATION:2||MicroRNA:2||miR146a:2||lupus nephritis:2||rheumatoid arthritis:2||osteoclastogenesis:2||bone remodeling:2||1,25Dihydroxyviamin D3:2||RANK:2||Asthma:2||Network analysis:2||arylhydrocarbon receptor:2||Immune response:2||Synovial macrophages:2||Vitamin D receptor:2||Bone mineral density:2||s disease:2||Multiple sclerosis:2||SLE:2||Monocytes:2||spondyloarthropathy:2||responsiveness:2||Interleukin10:2||CELLS:2||1:2||mTOR:2||Takayasu arteritis:1||Axial spondyloarthritis:1||FCGR3B:1||Copy number variation:1||MTHFR:1||Paraoxonase:1||IVC thrombosis:1||Prostaglandin D2 receptor:1||Wegener&apos:1||EVEROLIMUS:1||SYSTEM:1||CD226:1||SYSTEMICLUPUSERYTHEMATOSUS:1||LATVIAN PATIENTS:1||VARIANT:1||25(OH)2D3:1||INVIVO:1||COLLAGEN:1||Semaphorins:1||TNF inhibitors:1||25(OH)(2)D3:1||connective tissue disease:1||systemic sclerosis:1||Imaging:1||Etoricoxib:1||Celecoxib:1||Naproxen:1||mortality:1||OSTEOCLAST:1||Interferon regulatory factor 5:1||RAPAMYCIN:1||Protein tyrosine phosphatase nonreceptor 22:1||IL1 beta:1||STAT4:1||GENEEXPRESSION:1||INTERLEUKIN10:1||TRANSCRIPTION:1||SYNOVIALFLUID:1||BONE LOSS:1||Neuropilins:1||MOLIMMUNO:1||cytochrome P450:1||FCGR polymorphism:1||Synovium:1||Tolllike receptor:1||1 alpha,25dihydroxyviamin D3:1||Periodontitis:1||IL18:1||Interleukin18:1||Deep vein thrombosis:1||FAS:1||MAMMALIAN TARGET:1||ANALOGS:1||GENE:1||interleukin6:1||ERAP1:1||erythematosus:1||MECHANISMS:1||Phosphatidic acid:1||CEBP/beta:1||susceptibility:1||Calcium channel:1||MCSF:1||IFNgamma:1||RPL:1||Amyotrophic lateral sclerosis:1||psoriasis:1||TNFalpha polymorphism:1||GSTM1:1||TLR:1||MONOCYTES:1||PATHWAY:1||Rheumatic diseases:1||AUTOIMMUNEDISEASES:1||SURVIVAL:1||Genomewide association studies:1||Interleukin23R:1||REGION:1||PENTOSIDINE:1||Plexins:1||Neuropilin:1||METAANALYSIS:1||osteoclast:1||Smad1:1||pulmonary hypertension:1||Specificity:1||Protein S activity:1||s granulomatosis:1||Central nervous system involvement:1||MACROPHAGES:1||AUTOIMMUNE:1||DISEASES:1||Interleukin6:1||beta(2)glycoprotein I:1||ADAPTER PROTEINS:1||survival:1||항인지질항체 증후군:1||FCRL3:1||CFms:1||Sweet’s syndrome:1||Antineutrophil cytoplasmic antibody associated vasculitis:1||Pulmonary artery aneurysm:1||Endovascular embolization:1||Metaanalysis:1||Antiphospholipid syndrome:1||Psoriasis:1||Systemic lupus:1||systematic review:1||CFOS:1||TGFbeta:1||갑상선암:1||Bile acid receptor:1||TNF blockers:1||GSTs:1||TNFalpha:1||GSTT1:1||1,25dihydroxyvitamin D3:1||CYTOKINES:1||TRANSCRIPTION FACTORS:1||HETEROGENEITY:1||Cytotoxic T lymphocyte antigen4:1||CYP24:1||RANKL:1||DISEASE:1||Immune system:1||Semaphorin:1||Plexin:1||POLYMORPHISM:1||kynurenine:1||Differentiation:1||Smad3:1||Polygammaglutamic acid (gammaPGA):1||Giant cell arteritis:1||Sensitivity:1||TNFalpha inhibitors:1||angiotensinconverting enzyme:1||OSTEOCLASTS:1||EXPRESSION:1||FAMILIES:1||tacrolimus:1||1,25Dihydroxyvitamin D3:1||Osteoprotegerin:1||ALVEOLAR BONE LOSS:1||CUTTING EDGE:1||FC gamma RECEPTOR:1||RHEUMATOID ARTHRITIS:1||adjusted indirect comparison:1||

STATISTICS: Total View :6,091,682; Today View :3,905

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE